ArticleFrontiers in medicine2026
The red blood cell distribution width-to-albumin ratio and 28-day mortality in patients with severe cardiogenic shock: a retrospective cohort study based on MIMIC-IV with single-center external validation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiogenic shock (CS) is a critical syndrome with a very high fatality rate, and in-hospital mortality ranges from 27% to 51%. Among the various prognostic approaches, serum biomarkers have attracted considerable attention because they are easy to measure, inexpensive, and can be monitored dynamically. The red cell distribution width-to-albumin ratio (RAR) is a novel composite marker that integrates red blood cell heterogeneity (reflecting inflammation and oxidative stress) with albumin levels (indicating nutritional and anti-inflammatory capacity). It has shown initial promise for risk stratification in critically ill patients. However, the independent prognostic value of RAR specifically in CS remains unclear. Therefore, this study aims to systematically evaluate the ability of RAR to predict 28-day mortality in these patients. Materials and methods: This study used a two-cohort retrospective design. The internal training cohort was derived from CS patients in the MIMIC-IV v2.2 database, and the external validation cohort came from the medical record system of the Affiliated Hospital of Guizhou Medical University. To explore the association between RAR and short-term poor outcomes in severe CS, we applied multivariable Cox regression, restricted cubic spline (RCS) regression, subgroup analysis, and Kaplan-Meier survival curves. To develop a simple prediction model, the internal cohort was randomly split into a training set and a test set in a 7:3 ratio. In the training set, we used five methods-Boruta algorithm, LASSO-Cox regression, random forest (RF), gradient boosting (GBDT), and support vector machine (SVM)-to select key features associated with poor CS prognosis, covering laboratory indicators, comorbidities, demographic characteristics, and vital signs. Based on the selected feature variables, we built prognostic prediction models using multivariable Cox regression in each of the three cohorts. The discriminative ability of the model was compared with that of traditional disease severity scores using receiver operating characteristic (ROC) curves, with the area under the curve (AUC) as the measure of predictive performance. Result: A total of 1,314 CS patients were included in this study. In the fully adjusted model (Model 3), both continuous RAR and RAR quartiles were independently associated with 28-day adverse outcomes. For 28-day ICU mortality, each unit increase in RAR was associated with a 13.4% higher risk (HR 1.134, 95% CI 1.076-1.197, Conclusion: This study demonstrated in both cohorts that RAR is an independent associated with 28-day mortality risk in CS patients. The prediction model built on RAR and five other clinical features exhibited good clinical performance. With further prospective validation, this model may become a valuable exploratory tool for risk stratification in CS patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.